Antiviral Drugs Advisory Committee
November 14, 2002 Meeting
Additional Meeting Participants
Acting Industry Representative (non-voting)
Eugene Sun, M.D.
Divisional Vice President, Metabolic and Infectious Diseases Development
Global Pharmaceutical Research & Development
200 Abbott Park Road, Dept. R48U, Bldg. AP30-3
Abbott Park, Illinois 60064-6146
Miriam J. Alter, Ph.D. (Consultant – Center for Biologics Evaluation and Research)
Acting Associate Director for Epidemiologic and Public Health Science
Division of Viral Hepatitis (MS G37)
Centers for Disease Control and Prevention
Atlanta, Georgia 30333
Thomas R. Fleming, Ph.D. (Member – Cardiovascular and Renal Drugs Advisory Committee)
Professor and Chair
Department of Biostatistics
University of Washington
Seattle, Washington 98195-7232
Victoria A. Johnson, M.D.
Associate Professor of Medicine and Microbiology
Division of Infectious Diseases
Department of Medicine
229 Tinsley Harrison Tower
1900 University Boulevard
Birmingham, Alabama 35294-0006
Maria H. Sjogren, M.D. (Member – Gastrointestinal Drugs Advisory Committee)
Chief, Department of Clinical Investigation
Walter Reed Army Medical Center
6825 16th Street, N.W.
Washington, DC 20307
Samuel So, M.D.
Director, Asian Liver Center
Director, Liver Cancer Program
Associate Professor of Surgery
Stanford University School of Medicine
300 Pasteur Drive, H3680
Stanford, California 94305
Brian Wong, M.D.
Associate Professor of Medicine
Chief, Infectious Diseases Section
VA Connecticut Healthcare System
950 Campbell Avenue
West Haven, Connecticut 06516
HHS Federal Employee (non-voting)
Jay H. Hoofnagle, M.D.
Director, Division of Digestive Diseases and Nutrition
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Bldg. 31, Room 9A23
Bethesda, Maryland 20892
Patient Representative (non-voting)
President, Visionary Health Concepts
224 Centre Street
New York, New York 10013
Open Public Hearing Speakers
Brian Murphy, M.D., M.P.H. – InterMune, Inc.
Rebecca Welch – Axium Healthcare, Inc.